ArticleCancer science2010

Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells.

Hitoji Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.